Empress Therapeutics

Empress

This company develops small molecule medicines and a drug discovery platform for pharmaceutical firms to treat various human diseases.

Orogen Therapeutics

Orogen Therapeutics develops small-molecule drugs for autoimmune and immuno-inflammatory diseases using an AI-enabled DNA-encoded library platform to identify novel chemical matter for patients.

OMass Therapeutics

This company develops small molecule therapeutics for patients with immunological and rare diseases using a proprietary native mass spectrometry platform.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Empirico

The company develops genetic medicines and target discovery platforms for pharmaceutical partners and patients with common diseases.

Eikon Therapeutics

This biopharmaceutical company develops small molecule medicines for patients with cancer and other serious diseases using a live-cell imaging drug discovery platform.

Enveda Bioscience

This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.

Principia Biopharma

The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.